share_log

Why Is Insurance Firm Centene Stock Trading Higher On Thursday?

Why Is Insurance Firm Centene Stock Trading Higher On Thursday?

为什么保险公司康西哥的股票在周四上涨?
Benzinga ·  12/12 09:41

On Thursday, Centene Corporation (NYSE:CNC) outlined its 2025 financial guidance.

周四,康西哥公司(纽交所:CNC)概述了其2025年的财务指导。

For fiscal year 2025, the health insurance plan provider expects total revenues of $166.5 billion to $169.5 billion, compared to a consensus of $166.58 billion.

对于2025财年,该健康保险计划提供商预计总收入在1665亿到1695亿之间,而市场共识为1665.8亿。

The guidance includes premium and service revenues of $154.0 billion to $156.0 billion. The company expects GAAP EPS of greater than $6.19, with adjusted EPS of greater than $7.25 compared to the consensus of $6.97.

该指导包括1540亿到1560亿的保费和服务收入。公司预计GAAP每股收益大于6.19美元,调整后的摊薄后每股收益大于7.25美元,而市场共识为6.97美元。

Also Read: Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare

相关阅读:特朗普的第二个任期可能重塑美国医疗保健体系,对可负担医疗法案和医疗保险造成重大影响。

The company expects a Health benefits ratio (HBR) of 88.4% to 89.0%.

公司预计健康福利比率(HBR)在88.4%到89.0%之间。

The insurer forecasts a 2025 selling, general, and administrative (SG&A) expense ratio of 8.1% to 8.7%, with an adjusted SG&A expense ratio of 8.1% to 8.7%.

该保险公司预计2025年的销售、一般和管理(SG&A)开支比率为8.1%到8.7%,调整后的SG&A开支比率为8.1%到8.7%。

The company reaffirms its 2024 premium and service revenues guidance if $143.5 billion to $144.5 billion, HBR guidance if 88.3% to 88.5%, and adjusted diluted EPS guidance of greater than $6.80.

公司重申2024年保费和服务收入指导为1435亿到1445亿,HBR指导为88.3%到88.5%,以及调整后的摊薄后每股收益指导大于6.80美元。

"Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customers and providers, all while delivering on our financial commitments," said Chief Executive Officer of Centene, Sarah London.

“康西哥是一家以使命为导向的组织,致力于为2800万多名成员提供高质量的成果,其中许多人属于全国最复杂的医疗和历史上服务不足的人群。在过去三年中,我们改善了核心业务,并投资于客户和供应商的体验,同时履行我们的财务承诺,”康西哥首席执行官莎拉·伦敦(Sarah London)说。

Full-year 2024 earnings will be reported on February 4, 2025.

2024年全年收益将于2025年2月4日公布。

Price Action: CNC stock is up 1.92% at $57.99 at the last check on Thursday.

价格走势:CNC股票在周四最后检查时上涨1.92%,报57.99美元。

  • Keros Therapeutics Loses 75% Value In A Single Session – Here's Why
  • Keros Therapeutics在单个交易日内损失75%的价值——这就是原因。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发